Acquisition Opportunity Hayden Consulting Group was acquired by BGB Group in January 2026, indicating a potential cross-sell of Market Access and Patient Services capabilities to a larger platform and its clients, as well as integration opportunities for combined offerings.

Life Sciences Focus The firm specializes in strategy and analytics for commercialization and market access in life sciences, presenting ongoing sales opportunities with biotech and pharma companies navigating access barriers, payer strategies, and patient access programs.

Mid Market Strength With a mid-size profile (51-200 employees) and revenue in the substantial range, Hayden Consulting targets mid to large life sciences accounts that require sophisticated access and commercialization insights, aligning with enterprise clients seeking specialized consulting.

Leadership Additions Past hires of principals and directors (Jennifer Johnson and Andy Pollpeter) signal a strategy of strengthening leadership depth and domain expertise, which can be leveraged to position premium advisory services and expand into new life sciences segments.

Technology Enablement The tech stack and digital infrastructure (Cloudflare, Shopify, PHP, SEEK) suggest capabilities in scalable digital engagement and data-driven services, offering opportunities to package analytics, market access insights, and client-facing platforms.